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ABSTRACT 
 
 
The field of Tissue Engineering has developed in response to the shortcomings associated to the 
replacement of tissues lost to disease or trauma: donor tissue rejection, chronic inflammation, 
and donor tissue shortages. The driving force behind Tissue Engineering is to avoid these 
problems by creating biological substitutes capable of replacing the damaged tissue. This is done 
by combining scaffolds, cells and signals in order to create living, physiological, three-
dimensional tissues. Scaffolds are porous biodegradable structures that are meant to be colonized 
by cells and degrade in time with tissue generation. Scaffold design and development is mainly 
an engineering challenge, and is the goal of this thesis. 
The main aim of this thesis is to develop and characterize scaffolds for Tissue 
Engineering applications. Specifically, its objectives are: 
 To study scaffold processing method: Phase Separation. This is done by experiment 
design analysis. 
 To characterize the behavior of the scaffolds produced. 
The scaffolds are prepared using a biodegradable polymer polycaprolactone by thermally 
induced phase separation technique using solid-liquid phase separation. The porosity, 
crystallinity and pore size was characterized using scanning electron microscopy (SEM), 
differential scanning calorimeter (DSC), Mercury porosimeter, and X-ray diffraction (XRD). The 
parameters that found to influence the architecture of the scaffolds were freezing temperature, 
freezing medium and polymer concentration. The freezing temperature was found to have a 
profound effect on the pore size and final morphology of the porous structures. The degree of 
crystallinity determined using XRD was comparable with that of the as received PCL. The 
porosity of the structures was found to be 90-97%. The porosity of the PCL structures can be 
controlled by the concentration of the polymer solution used. Micrographs of the samples from 
the SEM revealed that the pore size was smaller when the polymer solution was quenched to 
lower temperatures (-20
0
C). Mercury porosimeter resulted in a pore size distribution from 50-
100µm which makes them suitable for tissue engineering applications. PCL scaffolds therefore 
may have considerable potential as scaffold for tissue engineering.
 
 
 
 
 
 
 
 
 
 
Chapter-1 
Introduction 
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INTRODUCTION 
 
Accidents and diseases lead to devastating tissue losses and organ failures which 
represents a life threatening situation. Tissue repair by autologous cell/tissue transplantation is 
one of the most promising techniques for tissue regeneration. Autografting and allografting are 
the two main approaches currently used to repair or replace damaged or lost tissue and organs. 
However, autografts are associated with limitations such as donor site morbidity and limited 
availability. On the other hand allografts are not limited in supply; however, they have the 
potential to cause an immune response and also carry the risk of disease transfer. Tissue 
engineering has emerged as an excellent approach for the repair/regeneration of damaged tissue, 
with the potential to circumvent all the limitations of autologous and allogenic tissue repair 
 
Tissue engineering is a new approach to resolve the missing tissue and organ problems. 
Therefore Tissue engineering represents an emerging multidisciplinary field which involves the 
“application of the principles and methods of engineering and life sciences towards the 
fundamental understanding of structure-function relationships in normal and pathological 
mammalian tissues and the development of biological substitutes that restore, maintain or 
improve tissue function”.  
There are three strategies in tissue engineering; 
(1) The use of isolated cells or cell substitutes to replace those cells that supply the needed 
function, including genetic or other manipulations before the cell infusion.  
(2) The delivery of tissue-inducing substances, such as growth and differentiation factors, to 
targeted locations. 
(3) Growing cells in three-dimensional (3-D) matrices (scaffolds) or devices, where cells can be 
either recruited from the host tissues in vivo or seeded (encapsulated) in vitro. 
 
Biomaterials play a crucial role in tissue engineering by serving as 3D synthetic 
frameworks commonly referred to as scaffolds, matrices, or constructs for cellular attachment, 
proliferation, and in growth ultimately leading to new tissue formation. Both synthetic polymers 
and biologically derived (or natural) polymers have been extensively investigated as 
biodegradable polymeric biomaterials. In contrast, synthetic polymers have great design 
     
2 
 
flexibility because the composition and structure can be tailored to the specific needs. A number 
of novel approaches have been developed for the fabrication of biomaterial-based 3D scaffolds.  
 
The scaffolds with high surface area to volume ratio favors cell adhesion, proliferation, 
migration, and differentiation, all of which are highly desired properties for tissue engineering 
applications. Therefore, current research in this area is driven towards the fabrication and 
characterization of scaffolds for tissue engineering applications. 
 
 
 
 
 
 
 
 
 
 
Chapter-2 
Literature survey 
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2.1 Scope and objective 
In designing scaffolds for tissue engineering, the principal objective will remain the 
optimal recreation of ECM function in a temporally coordinated and spatially organized 
structure.  The goal of this study is to fabricate scaffolds of the resorbable polymer poly (ε-
caprolactone) and successfully characterization of these scaffolds. The idea of using this unique 
method of fabrication is that these scaffolds will provide a greater surface area for direct cell 
adhesion and provide even more guidance of cell growth. The resorbable nature of the polymer 
will allow for a minimum mechanical stability to support the initial cellular growth and provide 
an anchor for future implantation, but then allow the tissue to encourage regeneration at the site 
of implantation.  
 
2.1.1 Tissue engineering: history, definitions and applications 
The field of tissue engineering developed as a response to the problems associated with 
the replacement of tissues lost to disease or trauma. Currently, tissue replacements must 
overcome important challenges such as rejection, chronic inflammation and severe organ donor 
shortages [1]. In fact, thousands of patients die every year in waiting lists for organ 
transplantation [2]. The driving force behind tissue engineering is the desire to avoid these 
problems by creating biological substitutes capable of replacing the damaged tissue. 
 
Nowadays, damaged tissue can be replaced by xenografts, allografts or autografts. A 
xenograft is a graft of tissue proceeding from another species. Xenografts offer the advantage of 
availability in a variety of shapes and sizes, but they also imply a nonnegligible risk of 
immunological reactions and infections. Allografts are grafts made of tissue from a human 
donor, usually post-mortem. This tissue must be thoroughly sterilised in order to avoid 
immunological reactions in the receiver and infections. Their limitations include donor shortages 
and risks of infections mentioned above. Autografts are grafts made of tissue obtained from the 
patient who receives the graft: a self-transplant of tissue in other words. Autografts are in some 
way a gold standard because they avoid most problems related to transfection and rejection. 
They do involve significant donor site morbidity and chronic donor shortages however. For 
example, in the case of bone replacement with tissue from the iliac crest, patients often complain 
of more pain in the hip area (iliac crest) than at the implantation site. 
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The idea behind tissue engineering is to create or engineer autografts, either by expanding 
autologous cells in vitro guided by a scaffold, or by implanting an acellular scaffold in vivo and 
allowing the patient‟s cells to repair the tissue guided by the scaffold. In both cases, the scaffold 
should degrade in time with tissue regeneration, so that once the tissue has matured the scaffold 
no longer exists as such and the newly created tissue can perform the function of the lost tissue 
[3]. This approach avoids some of the drawbacks of the grafting techniques discussed above. 
Namely, small numbers of cells are harvested from the patient, thus avoiding the problems of 
tissue shortage and donor-site morbidity. The cells are seeded into a scaffold which will 
eventually degrade completely, thus eliminating the presence of a foreign body at the 
implantation site and its consequent chronic inflammation. Finally, the use of autologous cells 
avoids problems of rejection and transfection (Figure 1.1). 
 
Figure 1.1: Schematic diagrams of the different phases in Tissue Engineering, from scaffold 
fabrication and cell isolation to in vivo implantation 
 
The term tissue refers to: an aggregate of cells usually of a particular kind together with their 
intercellular substance that form one of the structural materials of a plant or an animal. This 
intercellular substance, or extracellular matrix, is a crucial part of a tissue and acts both as a 
structural framework and as a regulator of cell behavior. The word engineering is defined as: a) 
to contrive or plan out usually with more or less subtle skill or craft, and b) to guide the course 
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of. In effect, Tissue Engineering uses multidisciplinary tools to produce a surrogate extracellular 
matrix meant to guide cells into creating new tissue [4]. 
One of the classical definitions of Tissue Engineering was postulated by Langer and 
Vacanti in 1993 as: 
• “…an interdisciplinary field that applies the principles of engineering and the life 
sciences toward the development of biological substitutes that restore maintain, or improve the 
tissue function.[5]” 
Many other, more or less similar definitions of tissue engineering can be found in the literature. 
Being a relatively new field, tissue engineering, is not always clearly defined, and may span from 
decellularised extracellular matrices, to exclusively cellular implants or non-biodegradable 
biomaterial scaffolds.  
Some examples of these definitions are: 
• “... The process of creating living, physiological, three-dimensional tissues and organs 
utilizing specific combinations of cells, cell scaffolds, and cell signals, both chemical and 
mechanical. [6]” 
• “...some combination of cells, scaffold material, and bioactive peptides used to guide 
the repair or formation of tissue. [7]” 
• “…the three-dimensional assembly over time of vital tissues/organs by a process 
involving cells, signals and extracellular matrix. [4]” 
• “The field of tissue engineering exploits living cells in a variety of ways to restore, 
maintain, or enhance tissues and organs [8]” 
• “…products or processes that (1) combine living cells with biomaterials, (2) utilize 
living cells as therapeutic or diagnostic reagents, (3) generate tissues in vitro for therapeutic 
implantation, and (4) provide materials or technology to enable any of these approaches.[9]” 
 
Already, one can infer two of the basic building blocks of tissue engineering: a) cells, and b) 
scaffolds. The third building block is signalling; biochemical and biomechanical signals which 
will coax the cells into creating tissue. Alternatively, these concepts can be interpreted as: a) 
biological and b) engineering challenges [8], bearing in mind that engineering challenges span 
both cell, scaffold, and signal treatment and vice versa. Thus the field of tissue engineering must 
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combine the knowledge and practices of life scientists and engineers in order to create viable 
tissues. 
 
Cells are one of the basic components of tissue and are critical in all tissue engineering 
applications [4; 8; 10]. Whether cells are directly implanted into the body or are cultured in vitro 
before implantation, their source and type must be chosen carefully. Furthermore, the harvesting, 
expansion and differentiation of cells imply many challenges which have retarded the 
implementation of cellular grafts. Skin tissue engineering grafts such as Apligraf® and 
Dermagraft® are the exception, partly due to the relative simplicity of the structure of skin as an 
organ, and partly due to the ease with which skin cells can be cultured and expanded in vitro 
maintaining the appropriate phenotype [8]. 
 
  If one considers the cellular approach, the first issue is the cell source: autologous, 
allogenic, or xenogenic, with the advantages and disadvantages discussed above. Due to the 
problems associated with the expansion and maintenance of the phenotypes of cells, cell type is 
also critical. Cells can be adult or embryonic stem cells (pluripotent, totipotent …) capable of 
self-renewal and differentiation into various cell lineages. They can also be adult cells at 
different stages of maturation and differentiation. Cells can also be generated by nuclear 
transplantation or manipulation ex-vivo [4]. Though stem cells hold enormous promise for this 
application, stem cell technology is still rather recent and must solve numerous engineering and 
ethical shortcomings. The chosen cell source and type should also guarantee sufficient supply 
and be free of pathogens and contamination. 
 
  Once cells are harvested they must be kept alive and expanded for a certain time in vitro. 
During this phase, cells must retain the desired phenotype be it undifferentiated or differentiated. 
Finally, the cells must be seeded onto a scaffold and should retain their function within the 
construct. Thus, the construct must also provide the mechanical and chemical cues the cells 
require. 
The signals the cells receive from their environment (in this case the scaffold) will in fact 
determine whether the scaffold turns into integrated tissue. First of all the right cell types must 
adhere to the outer surface of the scaffold and be able to migrate into it. This is achieved if the 
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scaffold has cell-adhesion sites distributed with the appropriate density to promote cell migration 
[11]. 
Once the cells have colonised the scaffold, they should begin proliferation or 
differentiation in order to produce the tissue which is being replaced. Cells receive the cues for 
proliferation or differentiation via the integrins with which they anchor onto the extracellular 
matrix (ECM) or scaffold, and via growth factors and cytokines. The mechanical stimuli they 
receive also induce mechanotransduction which allows them to behave and thus remodel tissue 
in function of the mechanical environment. The integrin-mediated signalling pathway is indeed 
complex. Cells attach onto proteins of the ECM via integrins and apply traction forces on them, 
thus stretching the ECM which in turn extends proteins revealing hidden binding sites on the 
protein structure. The ECM is thus an active environment that interacts with the cells very 
differently than the relatively passive artificial scaffolds [12-16] (Figure 1.2). The addition of 
growth factors in scaffolds may solve the challenges of inducing cell proliferation and 
differentiation. The dosage and distribution of the growth factors within the scaffolds, however, 
is not straightforward. In any case, signalling and cellular mechanotransduction are critical issues 
in tissue engineering. They determine cell phenotype, proliferation and differentiation [3; 4]. 
 
Figure 1.2: Schematic image of the dynamic reciprocity between cells and their extracellular 
matrix [11]. 
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Scaffolds are the other major component of the tissue engineering approach; the choice of 
scaffold includes its constitutive material, its design and the surface or molecular treatment it 
may carry. First of all, the biomaterials the scaffolds are made of must be biocompatible. In 
addition to its biocompatibility, the material‟s chemical and physical configuration must be 
adequate for the application, this includes its degradability. The degradation of the biomaterial 
should be in phase with and of course should not harm tissue regeneration. Degradation by-
products should not be toxic and should be easily and rapidly removed or diluted at the 
implantation site. The ability to eliminate the degradation by-products will largely depend on 
scaffold design. The design of the scaffold is another crucial issue. This design will determine its 
structure, porosity and interface with the cells and surrounding materials. The design must also 
be adapted to the application creating scaffolds with cubic or tubular pore shapes, for example. 
 
Furthermore, the biomaterial must be processable, a major challenge in the case of brittle 
ceramic biomaterials for example. Ease of processability, such as easy conformation or 
injectability in the case of plastics can often determine the choice of a certain biomaterial. The 
combination of biomaterial and scaffold design will in turn determine the ease and cost of 
manufacture, manipulation and sterilisation of the construct. 
 
2.2 Biomaterials for Tissue engineering applications 
A biomaterial is a “material intended to interface with biological systems to evaluate, 
treat, augment or replace any tissue, organ or function of the body” [17]. As Hench and Polak 
describe in their key article [18] published in 2002, biomaterials have evolved during the past 50 
years, and can now be considered “third-generation biomaterials”. Initially, biomaterials were 
chosen because of their biological inertness, the goal was to minimize the body‟s immune 
response to the foreign material. Though this goal is still valid today, scientists have come to 
understand that complete biological inertness is synonym to non-recognition by the body. This 
lack of biological recognition is often accompanied by fibrous tissue encapsulation and chronic 
inflammation, which in turn compromise the mechanical performance and long-term 
biocompatibility of the prosthesis. Thus, second-generation biomaterials were developed seeking 
to tailor or enhance biological recognition in an attempt to improve the biomaterial-body 
interface. Second generation biomaterials used bioactive components that could elicit a 
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controlled action and reaction in the physiological environment. Two very typical examples of 
these components are synthetic hydroxyapatite and Bioglass®. Both were used as porous 
scaffolds, coatings or powders, and by the mid-80s these new bioactive materials had attained 
clinical use for various dental and orthopedic applications. The biomaterial-body interface 
problem was also addressed by exploiting resorbable materials, thus eliminating the interface all 
together. Resorbable polymers are the main example of these resorbable materials, namely 
polylactic and polyglycolic acid which decompose hydrolytically into H2O and CO2. They are 
used as sutures, screws in orthopedics and in controlled-release drug-delivery systems. Third-
generation biomaterials are being designed at present, expanding the concept of biological 
recognition to specific biological recognition. Thus, third generation biomaterials aim to 
stimulate precise cellular responses:  interaction with distinct integrins, stimulation of cell 
differentiation or the activation of certain genes. It is also important to emphasize that these 
biomaterials are being designed. That is, third generation biomaterials are no longer borrowed 
from existing materials and adapted to a medical application. Instead, they are being designed 
prior to their development. In this way, the properties of bioactivity and resorbability are being 
combined to create materials capable of helping the body repair itself better or faster than it 
could do on its own. 
 
Typically, biomaterials can be divided into: polymers, metals, ceramics and natural 
materials. The material used in this thesis is a typical third-generation biomaterial. A resorbable 
polycaprolactone polymer has been used in this study. This material has then been shaped and 
processed into a scaffold for tissue engineering applications. A detailed description about this 
material has been given in the next section. 
 
2.2.1 Polymer-based scaffold materials  
The meaning and definition of the words biodegradable, bioerodable, bioresorbable and 
bioabsorbable (Table 1) are of importance to discuss the rationale, function as well as chemical 
and physical properties of polymer-based scaffolds [19]. In this thesis, the polymer properties are 
based on the definitions given by Vert [20].  
The tissue engineering program in this research curriculum has been classified into two phases 
(Table 2). Each tissue engineering phase must be understood in an integrated manner across the 
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research program from the polymer material properties, to the scaffold micro- and macro 
architecture. Hence, the research objectives in each phase are cross-disciplinary and the sub-
projects are linked horizontally as well as vertically. 
Table 1 
 
Biodegradable are solid polymeric materials and devices which break down due to 
macromolecular degradation with dispersion in vivo but no proof for the elimination from the 
body (this definition excludes environmental, fungi or bacterial degradation). Biodegradable 
polymeric systems or devices can be attacked by biological elements so that the integrity of the 
system and in some cases but not necessarily, of the macromolecules themselves, is affected and 
gives fragments or other degradation by-products. Such fragments can move away from their site 
of action but not necessarily from the body. 
Bioresorbable are solid polymeric materials and devices which show bulk degradation and 
further resorb in vivo; i.e. polymers which are eliminated through natural pathways either 
because of simple filtration of degradation by-products or after their metabolization. 
Bioresorption is thus a concept which reflects total elimination of the initial foreign material and 
of bulk degradation by-products (low molecular weight compounds) with no residual side 
effects. The use of the word „bioresorbable‟ assumes that elimination is shown conclusively. 
Bioerodible are solid polymeric materials or devices, which show surface degradation and 
further, resorb in vivo. 
 Bioerosion is thus a concept, too, which reflects total elimination of the initial foreign material 
and of surface degradation by-products (low molecular weight compounds) with no residual side 
effects.  
Bioabsorbable are solid polymeric materials or devices, which can dissolve in body fluids 
without any polymer chain cleavage or molecular mass decrease. For example, it is the case of 
slow dissolution of water-soluble implants in body fluids. A bioabsorbable polymer can be 
bioresorbable if the dispersed macromolecules are excreted. 
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Table 2 
The research program for tissue engineering is classified into two phases: 
 
 
I-Fabrication of bioresorbable scaffold 
II-Characterization of the scaffold 
 
2.2.2.1  Natural polymers for scaffolds  
Many naturally occurring scaffolds can be used as biomaterials for tissue engineering 
purposes. One example is the extracellular matrix (ECM), a very complex biomaterial 
controlling cell function that designs natural and synthetic scaffolds to mimic specific functions. 
Natural polymers include alginate, proteins, collagens (gelatin), fibrins, albumin, gluten, elastin, 
fibroin, hyarulonic acid, cellulose, starch, chitosan (chitin), scleroglucan, elsinan, pectin (pectinic 
acid), galactan, curdlan, gellan, levan, emulsan, dextran, pullulan, heparin, silk, chondroitin 6-
sulfate, polyhydroxyalkanoates, etc. Much of the interest in these natural polymers comes from 
their biocompatibility, relative abundance and commercial availability, and ease of processing 
[21]. Natural polymers possess several inherent advantages such as bioactivity, the ability to 
present receptor-binding ligands to cells, susceptibility to cell-triggered proteolytic degradation 
and natural remodeling. The inherent bioactivity of these natural polymers has its own 
downsides. These include a strong immunogenic response associated with most of the polymers, 
the complexities associated with their purification and the possibility of disease transmission 
[22]. 
 
2.2.2.2 Synthetic polymers for scaffolds        
 Natural polymers are typically in short supply because they are expensive, suffer from 
batch-to-batch variation, and are susceptible to cross-contamination from unknown viruses or 
unwanted diseases. On the contrary, synthetic polymeric biomaterials have easily controlled 
physicochemical properties and quality, and have no immunogenicity. They can also be 
processed with various techniques and consistently supplied in large quantities. In order to adjust 
the physical and mechanical properties of tissue-engineered scaffolds at a desired place in the 
human body, the molecular structure and molecular weight are easily adjusted during the 
synthetic process. Synthetic polymers are largely divided into two categories: biodegradable and 
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non-biodegradable. Some non-biodegradable polymers include polyvinyl alcohol (PVA), 
polyhydroxyethymethacrylate (PHEMA), and poly(N-isopropylacrylamide) (PNIPAAm). Some 
synthetic biodegradable polymers are the family of poly(α-hydroxy esters) such as polyglycolide 
(PGA), polylactide (PLA) and its copolymer poly(lactide-co-glycolide) (PLGA), 
polyphosphazene, polyanhydride, poly(propylene fumarate), polycyanoacrylate, poly(ε-
caprolactone) (PCL), polydioxanone (PDO), and biodegradeable polyurethanes. Of these two 
types of synthetic polymers, synthetic biodegradeable polymers are preferred for the application 
of tissue engineered scaffolds because they minimise the chronic foreign body reaction and lead 
to the formation of completely natural tissue. That is to say, they can form a temporary scaffold 
for mechanical and biochemical support [23]. Synthetic biomaterials on the other hand are 
generally biologically inert, they have more predictable properties and batch-to-batch uniformity 
and they have the unique advantage having tailored property profiles for specific applications, 
devoid of many of the disadvantages of natural polymers. Hydrolytically degradable polymers 
are generally preferred as implants due to their minimal site-to-site and patient-to-patient 
variations compared to enzymatically degradable polymers [24]. 
  
2.3 Polymers for Tissue engineering applications: Polycaprolactone 
Polycaprolactone (PCL) 
 
Figure 2: Synthesis of polycaprolactone by ring-opening polymerization (ROP) of ε-
caprolactone. 
PCL is a semi crystalline aliphatic polyester and is of great interest as it can be obtained by ROP 
of a relatively cheap monomeric unit “ε -caprolactone” and is known for its extremely low Tg (-
60
o
C) and long-term degradation properties (>24 months to lose total mass). The low melting-
point makes the material suited for composting as a means of disposal, due to the temperature 
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obtained during composting routinely exceeding 60
o
C [25]. PCL is an attractive polymer to use 
based on its elastomeric properties and high elongation [26]. For biomedical applications, PCL 
has been approved for use by the FDA since the 1970s and can be found in many common 
sutures and suture components. In the recent past, PCL has been used more and more by tissue 
engineers. Specifically with PCL, some of its attractive qualities are its enhanced solubility in 
organic solvents, ability to be processed at low temperatures, and its non-toxic degradation 
byproducts. One of its most attractive qualities for use in biomedical applications is its slow rate 
of degradation. PCL degrades by hydrolysis and will lose about 50% of its strength in 8 weeks 
using an in vitro degradation test [27]. Because of its attractive mechanical properties and ability 
to blend easily, many researchers have turned to using co-polymerizations of PCL with various 
starches to reduce production costs and to also encourage cell growth with the presence of a 
natural biopolymer. When blended with starch, the non-isothermal crystallization rate of PCL is 
increased. This reinforced PCL and its damping properties, provide attractive qualities for 
biomedical applications that undergo extensive mechanical strain, such as orthopedic implants 
[27]. PCL has also been blended with higher amounts of starch to increase its degradation rate. 
With higher starch content, PCL is more susceptible to enzymatic degradation by proteinase K49 
[29]. PCL has been blended with several other polymers, including PEO, PLA, and PGA in the 
past and has been used in many studies relating to biomedical applications. 
  
Like other polyesters, PCL will undergo auto-catalyzed bulk hydrolysis degradation 
because of the susceptibility of its aliphatic ester linkage. However, the hydrophobic, semi-
crystalline polymer retards degradation and resorption kinetics when compared to other aliphatic 
polyesters such as PLGA, which makes it more suitable for long term implantable devices [31-
32]. Bulk hydrolysis breaks the ester linkage, which creates fragmentation and the release of 
oligomeric species. Low molecular-weight fragments are eventually engrossed by giant cells and 
macrophages. The byproduct e-hydroxycaproic acid is either metabolized via the tricarboxylic 
acid (TCA) cycle or removed by direct renal secretion [33, 34, 35]. It is also possible for PCL to 
enzymatically degrade (enzymatic surface erosion) by lipases and esterases, though this is rare 
[36, 37].  
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2.3.1 Use in Tissue Engineering 
PCL has been used for several tissue engineering endeavors. The advantage in using 
these PCL scaffolds deals with its desirable biostability and mechanical qualities which ensures 
its long-term presence and elasticity. One study in particular has shown the use of PCL for skin 
grafts as a mix of collagen and PCL in a composite film [38]. The objective was to monitor the 
degradation of the collagen in a cultured environment and monitor the cell adhesion over several 
days. The study followed the behavior of several variations of the mixture of PCL and collagen. 
The resorption rate of about one year of the PCL showed promise for the use for developing skin 
grafts for burn victims. The PCL phase also provided the necessary stability for a graft of this 
nature. Unique for this study, was the ability to control the cell growth and adhesion by the 
amount of collagen in the initial mixture with PCL. Solutions with a higher PCL content showed 
ECM production with higher cell adhesion. This also suggested that there can be a way to 
manipulate the PCL/collagen solution within the scaffolds to develop a drug delivery system to 
continue the healing of the wound site. The resorption of the PCL over a year‟s time also aided 
in the healing process of the wound site and made the wound more apt to heal effectively.  
 
2.4 Importance of Scaffold Matrices in Tissue engineering  
Scaffolds play a critical role in tissue engineering. The function of scaffolds is to direct 
the growth of cells either seeded within the porous structure of the scaffold or migrating from 
surrounding tissue. The majority of mammalian cell types are anchorage-dependent, meaning 
they will die if an adhesion substrate is not provided. Scaffold matrices can be used to achieve 
cell delivery with high loading and efficiency to specific sites. Therefore, the scaffold must 
provide a suitable substrate for cell attachment, cell proliferation, differentiated function, and cell 
migration. The prerequisite physicochemical properties of scaffolds are many: to support and 
deliver cells; induce, differentiate, and channel tissue growth; target cell-adhesion substrates; 
stimulate cellular response; provide a wound-healing barrier; be biocompatible and 
biodegradable; possess relatively easy processability and malleability into desired shapes; be 
highly porous with a large surface/volume ratio; possess mechanical strength and dimensional 
stability; and have sterilisability, among others [39,40]. Generally, three-dimensional porous 
scaffolds can be fabricated from natural and synthetic polymers, ceramics, metals, composite 
biomaterials, and cytokine release materials. 
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Scaffold design and development is mainly an engineering challenge and is in fact the 
goal of this thesis. 
Tissue engineering scaffolds are meant to be colonised by cells and should transmit the chemical 
and physical cues necessary to ensure adequate tissue growth. An ideal tissue engineering 
scaffold should fulfill a series of requirements [41]: 
• It should have a reproducible microscopic and macroscopic structure with a high 
surface/volume ratio suitable for cell attachment. 
• The material it is made of should be biocompatible. The scaffold should perform its function 
with an appropriate response of the host and it should not induce adverse responses [42]. 
• The scaffold should have an adequate porosity; this includes the magnitude of the porosity, the 
pore size distribution and its interconnectivity.  
 This will allow cell in-growth and vascularisation, and 
 Promote metabolite transport 
• The scaffolds should have appropriate mechanical properties and support to resist 
physiological forces within the implantation site and similar flexibility to the surrounding tissue. 
Ideally it should support the mechanical load on the damaged tissue while it regenerates. 
• The scaffold material should be biodegradable. Its degradation products should not be toxic 
and should be easily eliminated from the implantation site by the body. 
• The scaffold‟s degradation rate should be adjusted to match the rate of tissue regeneration, so 
that it has disappeared completely once the tissue is repaired. 
 
2.4.1 Essential Scaffold Properties 
The porosity and pore size are key factors to the success of scaffold performance. The 
surface of the scaffold is the site of first contact for the cells, and therefore surface topography 
and surface energy are the next most important variables to be considered. When examining the 
porosity, the cellular in growth is a very important variable to consider. A highly porous scaffold 
will allow for cellular migration and good cell adhesion [43, 44]. The scaffold needs to allow for 
capillary ingrowth as well. With the fresh blood supply, comes the supply of fresh oxygen and 
nutrients necessary for cellular survival. Along with the vascularization, the ability to dispose to 
cellular waste also becomes available. Adequate porosity promotes vascularization and 
encourages angiogenesis [45]. However, too much porosity can cause the scaffold to lose all 
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mechanical integrity and be unable to support the cellular growth. Most previous researchers 
have demonstrated that highly porous structures are required with overall porosity values in the 
order of 90% as to have successful results [46]. The pore size is another important aspect to 
consider. When hoping to encourage the growth of a 3-D structure, there needs to be 
consideration for the size of the target cell. Surface coatings are another important aspect to 
include in the scaffold production. There has been significant success with the inclusion of 
natural polymers in conjunction with biodegradable synthetic polymers. The natural polymers 
and growth factors encourage the cell growth with no concern for cytotoxic effects. Through the 
fabrication process and ensuring the scaffold has 3-D shape and appropriate porosity and pore 
size distribution, as well as the necessary mechanical and tensile strength, the scaffold can also 
be made to include vital biological factors. These factors can be native ECM proteins or growth 
factors to stimulate tissue regeneration and healing. The most effective method to date has been 
the recent discovery of the advantages of coculture techniques. The field of tissue engineering 
tissue-specific extracellular matrices has come a long way since its beginning and still has a great 
potential to revolutionize the field of biotechnology.  
 
2.5 Fabrication of Tissue engineering Scaffolds. 
Different processing techniques have been developed for the design and fabrication of 
three-dimensional (3D) scaffolds suitable for TE implants. Conventional techniques for scaffold 
fabrication include gas foaming, fiber bonding, emulsification/freeze-drying, solvent 
casting/particulate leaching, thermally induced phase separation (TIPS), 3D-printing [47–50], 
Nanofiber Self-Assembly, Textile technologies [50], CAD/CAM technologies [51]. 
Detailed descriptions regarding each technique have been given below.  
Each of these techniques presents its own advantages, but none is devoid of drawbacks. 
 Nanofiber Self-Assembly: Molecular self-assembly is one of the few methods to create 
biomaterials with properties similar in scale and chemistry to that of the natural in vivo 
extracellular matrix (ECM). Moreover, these hydrogel scaffolds have shown superior in 
vivo toxicology and biocompatibility compared with traditional macroscaffolds and 
animal-derived materials. 
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 Textile technologies: these techniques include all the approaches that have been 
successfully employed for the preparation of non-woven meshes of different polymers. In 
particular non-woven polyglycolide structures have been tested for tissue engineering 
applications: such fibrous structures have been found useful to grow different types of 
cells. The principal drawbacks are related to the difficulties of obtaining high porosity 
and regular pore size. 
 Solvent Casting & Particulate Leaching (SCPL): this approach allows the preparation of 
porous structures with regular porosity, but with a limited thickness. First the polymer is 
dissolved into a suitable organic solvent (e.g. polylactic acid could be dissolved into 
dichloromethane), then the solution is cast into a mold filled with porogen particles. Such 
porogen can be an inorganic salt like sodium chloride, crystals of saccharose, gelatin 
spheres or paraffin spheres. The size of the porogen particles will affect the size of the 
scaffold pores, while the polymer to porogen ratio is directly correlated to the amount of 
porosity of the final structure. After the polymer solution has been cast the solvent is 
allowed to fully evaporate, then the composite structure in the mold is immersed in a bath 
of a liquid suitable for dissolving the porogen: water in case of sodium chloride, 
saccharose and gelatin or an aliphatic solvent like hexane for paraffin. Once the porogen 
has been fully dissolved a porous structure is obtained. Other than the small thickness 
range that can be obtained, another drawback of SCPL lies in its use of organic solvents 
which must be fully removed to avoid any possible damage to the cells seeded on the 
scaffold. 
 Gas Foaming: to overcome the necessity to use organic solvents and solid porogens a 
technique using gas as a porogen has been developed. First disc shaped structures made 
of the desired polymer are prepared by means of compression molding using a heated 
mold. The discs are then placed in a chamber where are exposed to high pressure CO2 for 
several days. The pressure inside the chamber is gradually restored to atmospheric levels. 
During this procedure the pores are formed by the carbon dioxide molecules that abandon 
the polymer, resulting in a sponge like structure. The main problems related to such a 
technique are caused by the excessive heat used during compression molding (which 
prohibits the incorporation of any temperature labile material into the polymer matrix) 
and by the fact that the pores do not form an interconnected structure. 
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 Emulsification/Freeze-drying: this technique does not require the use of a solid porogen 
like SCPL. First a synthetic polymer is dissolved into a suitable solvent (e.g. polylactic 
acid in dichloromethane) then water is added to the polymeric solution and the two 
liquids are mixed in order to obtain an emulsion. Before the two phases can separate, the 
emulsion is cast into a mold and quickly frozen by means of immersion into liquid 
nitrogen. The frozen emulsion is subsequently freeze-dried to remove the dispersed water 
and the solvent, thus leaving a solidified, porous polymeric structure. While 
emulsification and freeze-drying allows a faster preparation if compared to SCPL, since it 
does not require a time consuming leaching step, it still requires the use of solvents, 
moreover pore size is relatively small and porosity is often irregular. Freeze-drying by 
itself is also a commonly employed technique for the fabrication of scaffolds. In 
particular it is used to prepare collagen sponges: collagen is dissolved into acidic 
solutions of acetic acid or hydrochloric acid that are cast into a mold, frozen with liquid 
nitrogen then lyophilized. 
 Thermally Induced Phase Separation (TIPS): similar to the previous technique, this 
phase separation procedure requires the use of a solvent with a low melting point that is 
easy to sublime. For example dioxane could be used to dissolve polylactic acid, then 
phase separation is induced through the addition of a small quantity of water: a polymer-
rich and a polymer-poor phase are formed. Following cooling below the solvent melting 
point and some days of vacuum-drying to sublime the solvent a porous scaffold is 
obtained. Liquid-liquid phase separation presents the same drawbacks of 
emulsification/freeze-drying. 
 CAD/CAM Technologies: since most of the above described approaches are limited 
when it comes to the control of porosity and pore size, computer assisted design and 
manufacturing techniques have been introduced to tissue engineering. First a three-
dimensional structure is designed using CAD software, then the scaffold is realized by 
using ink-jet printing of polymer powders or through Fused Deposition Modeling of a 
polymer melt. 
The mixing of different polymers or polymer solutions is often accompanied by the 
phenomenon of phase separation. Thermally induced phase separation (TIPS) is currently 
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utilized to fabricate microporous membranes or microcellular foams [52-54]. This technique is 
based on the principle that a single homogeneous polymer solution made at elevated temperature 
is converted via the removal of thermal energy to two-phase separated domains composed of a 
polymer-rich phase and a polymer lean phase [55-57]. Subsequent freeze-drying of the liquid-
liquid phase-separated polymer solution produces microcellular structures as a result of solvent 
removal. A schematic temperature-composition phase diagram for a binary polymer-solvent 
system is represented in Fig. 3. It shows the expected variations in polymer foam morphology 
depending on the final thermodynamic state of the polymer solution to be thermally quenched. 
According to whether the quenching end point is located in the metastable region between 
binodal and spinodal curves or in the unstable region below the spinodal curve, two distinctive 
morphologies can be obtained: (i) a poorly interconnected bead-like structure by a nucleation and 
growth mechanism or (ii) a well-interconnected open porous structure by a spinodal 
decomposition mechanism. 
 
 
Figure 3: Schematic temperature-composition phase diagram for a two phase system with an 
upper critical solution temperature indicating a quench (arrowed) from the one-phase region into 
the unstable region where spinodal decomposition is the mechanism of phase separation. 
Nucleation and growth is the active mechanism or smaller quenches in to the metastable region 
[58]. 
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A thermally induced phase separation (TIPS) process has been used in this work for tailoring a 
biodegradable polycaprolactone support. Phase separation takes place on cooling and removal of 
the solvent results in a porous morphology. When the phase-separated system is stabilized by 
polymer crystallization of the polymer-rich phase, no shrinkage of the porous structure occurs 
upon solvent removal. Otherwise, the phase-separated system has to be frozen at a low enough 
temperature and the solvent has to be removed by sublimation.  
Polymer-solvent phase separation can be divided into  
(a) liquid-liquid phase separation, which may occur prior to the solvent freezing, and  
(b) solid-liquid phase separation, 
 
Figure 4: The schematic diagram of solid-liquid phase separation. 
 
Solid-liquid phase separation, also called emulsion freeze drying, could be achieved by lowering 
the temperature to induce solvent crystallization from a polymer suspension (solid phase 
formation in a liquid phase). This process takes place by a nucleation and growth mechanism. 
After the removal of the solvent crystals (sublimation or solvent exchange), the space originally 
taken by the solvent crystals becomes pores which is observed when the solvent has been 
completely frozen. This removal must take place at a temperature below the solvent 
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solidification curve in order to avoid the solvent re-dissolving the polymer. The removal is 
typically performed by freeze-drying, also called lyophilisation. During this process, the phase-
separated mixture is maintained at low temperatures and a high vacuum is applied in order to 
sublime the solvent. Alternatively, the solvent can be extracted by soaking the mixture in a 
substance which dissolves the solvent but not the polymer. This method, called freeze-extraction, 
was applied to polymeric scaffolds by Ho et al. [59] using ethanol. 
 
1,4-dioxane is used as the solvent for creating PCL phase-separated scaffolds. Its physical 
properties are very convenient for this procedure and have a high melting point and a low boiling 
point, 11.8°C and 102°C respectively [60]. These temperatures allow for thermally induced 
phase separation at high temperatures, and facilitate sublimation. 
 
The addition of a non-solvent to the polymer solution may induce liquid-liquid phase 
separation. 
 
Phase separation relies on no special equipment and allows for three-dimensional 
scaffolds to be created within the sub-micron range. This process forms a continuous fiber 
network that can be tailored to any application. Pore structure can easily be controlled and batch-
to batch consistency is high. Pore structure is easily varied by changing the solvent used in the 
process [61]. This change in solvent can change the phase separation process from liquid–liquid 
to solid–liquid depending on the solvent mixtures used thus changing the final pore morphology. 
Initial polymer concentration plays an important part in porosity of the final scaffold. High initial 
concentration of polymer leads to less porous network [62]. The ease with which these scaffolds 
can be created and the demonstrated ability of these highly porous networks to support cell 
growth makes them an attractive solution for creating the porous structures. 
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3. EXPERIMENTAL 
 
3.1 Materials  
Poly (ε-caprolactone) was purchased from Sigma-Aldrich with a molecular weight of 
Mn=80,000 in pellet form. The solvent used was 1, 4 dioxane ReagentPlus Grade, ≥99% purity, 
was purchased from Sigma Aldrich Pt Ltd.  
 
3.2 Scaffold fabrication 
 
3.2.1 Porous polymer material fabrication using freeze drying 
Typically three processing steps were taken to prepare a porous polymer material from a 
polymer solution: 
(A)    Accurately weighed polymer was added in to a flask and calculated amount of solvent     
was added in to the flask to make a polymer solution of desired concentration. In an 
embodiment the polymer solution (polymer/solvent mixture) contains about 1%, 3% 
and 5% polymer. Typically the polymer was dissolved for an hour or longer to ensure a 
homogeneous solution when stirred with a magnetic stirrer at either room temperature 
or an elevated temperature. The petri dish containing the polymer solution was then 
rapidly transeferred into a cooling device and frozen at -20
0
C using a freezer and at 6
0
C 
using a refrigerator. 
(B)    The frozen polymer solution was then freeze dried at a predetermined vacuum and 
predetrmined temperature for the removal of solvent. 
(C)   The dried porous polymeric material was then placed in a dessicator for further 
charecterization. 
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3.3 Characterization Methods 
 
3.3.1 Morphology 
A qualitative study of the scaffold morphology was performed on a JEOL JSM-6480 LV 
Scanning Electron Microscopy (SEM). Frozen cross sections of the scaffold, were coated with 
platinum using a JEOL JFC-1600 Auto Fine Coater operated at 20 mA for 80 s prior to SEM 
analysis and examined. 
 
3.3.2 Differential Scanning Calorimeter 
The thermal transitions of the scaffold material were measured by a Mettler Toledo DSC822e 
Differential Scanning Calorimeter. The samples used weighed between 10 and 15 mg and were 
submitted to a heating cycle at 20°C/min under nitrogen atmosphere: 
 First heating ramp: from -40°C to 100°C at 20°C/min. During this ramp, the material 
displays information on its actual physical and morphological state. This ramp is used to 
evaluate the heat of fusion, Hf, and melting temperature, Tm, of the material. 
 
 
Figure 5:  A schematic diagram of a heat flow curve of the polymer scaffolds.  
The glass transition temperature, Tg, appears as an inflection in the heat flow curve, it is 
defined as the inflection point of the region. It is mainly concerned about the amorphous regions 
of the polymer. 
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Crystallisation is an exothermal transition, it occurs at temperatures slightly lower than 
the melting point of the polymer. The crystallisation of a polymer depends on the capacity of its 
chains to move and form a crystalline structure. There can be a crystallisation peak in both the 
first and the second heating ramp. The HC is indicative of polymer chain length. The 
crystallisation temperature and enthalpy are defined as the maximum of the crystallisation peak 
and the area under the crystallisation curve respectively. 
Melting is an endothermal transition, the melting point is defined as the minimum of the 
melting peak. The melting point of the PCL used for this study ranges between 60
0
C. The heat of 
fusion is the area under the melting peak. Only the crystalline regions of the PCL have a melting 
temperature. 
The heat of fusion is thus used to compute the percentage crystallinity, XC calculated as: 
XC =  
Where, was the measured enthalpy of melting and  was the enthalpy of melting of 
100% crystalline polymer. For PCL,  = 139.5 J/g [63]. 
 
3.3.3 Porosity and pore size 
The porosity of the scaffolds was calculated as follows: 
Porosity = 100  
Where V= volume of the scaffold 
 Vp= volume of the polymer; obtained by dividing mass (M) by the density of the 
polymer. The density of the polymer was obtained from the supplier PCL (1.145g/cm
3
). 
 
3.3.3.1 Mercury intrusion Porosimeter 
Mercury intrusion Porosimeter (PMI 30K-A-1, Porous Materials, Inc., Ithaca, NY) was 
used to determine pore size distribution, total pore volume of the foams. Pore size was calculated 
from the measurement of the intruded mercury volume by raising pressure. 
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3.3.4 X-ray diffraction (XRD) pattern 
The crystal structure of the scaffolds was investigated by XRD analysis. The prepared 
scaffolds were cut in to slices and pressed into films which were then characterized using Philips 
X‟pert MPD diffractometer .The sample were scanned from 5  to 60  at a scanning rate of 
3.0 /min 
The equation of the degree of crystallinity is calculated as follows: 
 XC =  
Where: XC refers to the degree of crystallinity;  
Ac refers to the crystallized area on the X-ray diffractogram; 
Aa refers to the amorphous area on the X-ray diffractogram
 
 
 
 
 
 
 
 
Chapter-4 
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Results and Discussion 
The phase separation processing parameters and the composition of the polymer solution 
strongly influence the various characteristics of the porous structures formed. Quenching at low 
temperatures reduces pore size due to the nucleation phenomena. Quenching at high 
temperatures, on the other hand, tend to create larger pores due to existence of less nuclei and the 
prevalence of the growth phenomena. The quenching rate and the temperature at which solvent 
removal takes place also affect the pore size. Polymer concentration influences the density and 
thus the overall porosity of the structure. Both quenching parameters and polymer concentration 
influence the occurrence of solid-liquid phase separation. Semi-crystalline polymers tend to 
create more porous structures than their amorphous counterparts due to the higher contraction of 
the semi-crystalline phase during solidification.  
 
The influence of some of the key parameters such as quenching temperature, freezing 
medium, and polymer concentration on morphology and porosity of the scaffolds was studied.  
 
4.1 Effect of quenching temperature 
Quenching of polymer solution has a profound effect on the morphology of the scaffold. 
The effect of quenching temperature on scaffold morphology was studied by quenching the 
polymer solution at two different temperatures using a freezer (-20
0
C) and refrigerator (6
0
C). Fig 
8 shows the effect of quenching temperature on the resulting structures of scaffolds. Solid-liquid 
phase separation results in ladder or sheet like anisotropic morphologies which are strongly 
dependent upon the quenching temperature. Scaffolds quenched at lower temperature (-20
0
C) 
were found to have well defined pores throughout the architecture of the scaffolds in comparison 
with those quenched at higher temperatures. This is evident from the SEM analysis of the 
scaffolds as shown in Fig 6. The is due to the fact that quenching at higher temperature is 
induced by lower nucleation rate and high crystal growth rate resulting in large pore size. The 
determination of pore size distribution of the sample using mercury porosimeter also confirms 
the higher pore size (22µm-60µm) obtained at lower freezing temperature as shown in Fig 7.  
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The quenching temperature did not affect the overall porosity of the samples. Low PCL 
w/v %( 1 wt %) resulted in higher porosities (97%) than those with the high level of PCL w/v %( 
5 wt %) as shown in Table 3. 
 
SEM  
 
6
0
C       -20
0
C                           
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4.2 Effect of freezing medium 
The freezing medium is another important factor found to influence the pore size and the 
architecture of the scaffolds. In the present study the effect of freezing medium on the prepared 
structures was investigated using freezer and refrigerator as the freezing medium. The 
experimental result is shown in Fig 6. The figure shows the effect of two freezing mediums 
observed at varying polymer concentrations (1wt%, 3wt%, 5wt %). All the structures resulted in 
a well defined porous architecture expect at lower concentration (1wt %). The intention in 
studying two freezing mediums is that with freezer the porous structure resulted in a higher 
interconnectivity than when observed using refrigerator. The effect of average pore size observed 
at two freezing mediums as shown in Fig 7 is smaller in case of freezer rather than in 
refrigerator. A higher degree of supercooling resulted when the polymer solution was immersed 
in the freezer which gave rise to different crystallization kinetics, faster nucleation and slower 
growth of dioxane crystals in the polymer solution which resulted in different pore structures. 
The freezing mediums also had their effect on the porosities. A larger porosity of was obtained in 
case of freezer than the porosity obtained using refrigerator. 
 
Figure 6: SEM micrographs of foams fabricated by freeze-drying of 5, 3, and 1 wt. % PCL/1, 4-
Dioxane at -20
0
C using a freezer and at 6
0
C using refrigerator. 
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Figure 7: Effect of temperature, freezing medium and PCL/1, 4 dioxane concentration on pore 
size 
 
4.3 Effect of polymer concentration 
The polymer concentration is also an important parameter for the scaffold development. 
The different polymer concentration used in the study are 1, 3, 5 wt% to see their effect on the 
scaffold characteristics. The experimental results are tabulated in Table 3. The result shows that 
higher the concentration of PCL lower is the porosity. This is mainly attributed due to more 
matter remaining after solvent removal. Polymer concentration was found to affect the porous 
structures quenched at two different freezing temperatures (-20
0
C, 6
0
C). The scaffolds resulted 
were of highly porous with porosity values in the range of 90-97%. By varying the concentration 
of the polymer solution, as shown in Table 3, the porosity of the scaffolds could be controlled 
i.e. the porosity decreased with an increase in the polymer concentration and the density was 
found to increase (0.035-0.089 g/cm
3
). 
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Table 3. Porosities of the prepared PCL scaffolds obtained by freeze-drying. 
 
Polymer 
concentration 
wt% 
Freezing        
temperature 
( ) 
Porosity 
(%) 
Density 
(g/cm
3
) 
1 
6 97 0.035 
-20 
 
96.4 0.041 
3 
6 94 0.068 
-20 
 
93.6 0.073 
5 
6 91.6 0.081 
-20 89.7 0.089 
 
From Fig 6 we can see that by increasing the polymer concentration the pore structure is 
being developed from 1 wt% to 5wt% as irregular to well defined structures. 
 
4.4 Thermal properties of the scaffolds 
Thermal Analysis is mainly done to detect the changes in the heat content (enthalpy) or 
the specific heat of a sample with temperature.The melting behavior of the prepared matrices was 
characterized using differential scanning calorimeter. All the scaffolds prepared from PCL have 
shown melting temperature, Tm, in the range of 60.5 to 63
0
C. This melting temperature was 
similar to as-received PCL. The polymer crystal size in the scaffolds was similar to as the 
original pure polymer and was unaffected by the different processing parameters used during the 
fabrication process.  
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Table 4. Thermal properties (Tm) and porosity values of PCL scaffolds fabricated using 
freeze drying. 
 
Concentration 
wt (%) 
Freezing 
temperature( ) 
Freezing 
medium 
Melting 
temperature 
Porosity 
(%) 
1 
6 Refrigerator 61.36 97 
-20 freezer 63 96.4 
3 
6 Refrigerator 62.06 94 
-20 freezer 62.15 93.6 
5 
6 Refrigerator 61.75 91.6 
-20 freezer 60.50 89.7 
 
The PCL scaffolds retained their semi-crystalline morphologies irrespective of the 
various freezing conditions used during the samples preparation. 
 
4.5 XRD patterns 
The crystalline phases present in the samples were identified by XRD. XRD patterns of 
the resulting PCL scaffolds are shown in Fig 8. There are no diffraction peaks of other 
substances and all diffraction peaks are corresponding to PCL. PCL is a semi-crystalline polymer 
with two diffraction peaks, around 21  and 23 . Moreover, the peaks were sharp and distinct, 
which indicated that the samples were highly crystalline materials. Table 5 shows the degree of 
crystallinity obtained from XRD found to be in the range of 47-56%. Crystallinity range for the 
polymer polycaprolactone is in between 42-60%. The obtained results are in accordance with  
literature. 
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Table 5. Degree of crystallinity obtained from XRD 
 
 
Polymer concentration 
wt% 
Freezing temperature 
0
C 
Degree of crystallinity 
Xc (%) 
1 
6 56 
-20 54 
3 
6 62 
-20 52 
5 
6 51 
-20 47 
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Figure 8: XRD patterns for PCL of 5, 3, and 1 wt. % PCL/1, 4-Dioxane 
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Conclusion 
 
The main aim of the present investigation was to prepare scaffolds from synthetic polymer, PCL, 
to be used as extracellular matrix in Tissue engineering. Micro porous scaffolds with high 
anisotropy were fabricated from PCL by thermally induced using solid-liquid phase separation 
method. The key parameters of the solid-liquid phase separation technique such as quenching 
temperature, freezing medium and polymer concentration were found to influence the scaffold 
morphology.  
Interconnected porous structure of the scaffolds were obtained in the size range of 50 to 
100 µm. Porosity and density of the scaffold structures are strongly dependent on the initial 
concentration of polycaprolactone. The pore interconnectivity was lower at lower polymer 
concentrations at 1 wt%. Freezing temperature had a major impact on the scaffold morphology 
and the porosity. At lower freezing temperatures the scaffolds structures were homogeneous. The 
porosity was higher in case of lower freezing temperature in the range of 96% to 97%. The 
average pore size and porosity of scaffold increased with decreasing polymer concentration. 
Ladder like structure was obtained at high polymer concentrations. This work suggests a useful 
technique to control the expected micropore formation of the scaffold. Therefore with high 
porosity and interconnectivity these scaffolds serve as potential candidates for various tissue 
engineering applications.
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APPENDIX 
 
Pore size of PCL scaffolds fabricated using freeze drying. 
 
Polymer concentration 
wt% 
Freezing temperature  
( ) 
Pore size ( m) 
 
1 
6 45 8 
-20 22 6 
3 
6 87 12 
-20 56 11 
5 
6 65 4 
-20 37 2 
 
 
List of Instruments used during the whole experiment their make and function 
 
Instruments Manufacturer Function 
Magnetic stirrer Spint Mixing 
Lyophilizer lyolab Freeze-drying 
SEM  JEOL JSM-6480 LV Morphology 
DSC Mettler Toledo DSC822e Thermal properties 
XRD Philips X‟pert MPD 
diffractometer 
Crystallinity 
Mercury intrusion porosimter 
 
Quantachrome Pore size analyzer 
 
 
 
